A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients
NCT00591877 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2012-10-26
Summary
Patients with refractory GERD on BID PPI's assigned to the acupuncture group will have significant improvement in their symptoms after receiving acupuncture for 6 weeks as compared to sham acupuncture given for the same duration.
Primary Aim 1:To determine the efficacy of acupuncture in the treatment of refractory GERD.
Participants with refractory GERD on BID PPIs randomized to yoga will have a significant relief in the symptoms of reflux.
Primary Aim 2:To determine the efficacy of yoga in the treatment of refractory GERD.
Conditions
- Gastroesophageal Reflux Disease
Interventions
- PROCEDURE
-
Acupuncture
Each patient will undergo a 30 minute session, twice a week, for a total of 12 sessions. The technique will involve electro-stimulation at predefined points followed by needle manipulation. The acupoints that will be used are: * ST-36: 3 finger breadths inferior to lower edge of patella between tibialis anterior muscle and the tibia, 1 finger breadth lateral to the anterior crest of the tibia. * PC-6: 2 finger breadths proximal to and in the middle of the most distal transverse crease of the wrist, between the tendons of palmaris longus and flexor carpi radialis. * CV-12: 4 finger breadths superior to the umbilicus.
- PROCEDURE
-
Sham Acupuncture
The acupoints for SAC are: * LI-4 : adjacent to and at the middle of the radial side of the 2nd metacarpal bone, at the same level as the end of the crease when the thumb and index fingers approximate. * GB-32: on the lateral aspect of the thigh 5 finger breadths proximal to the popliteal crease, 2 finger breadths inferior to GB31. * UB -15: 1.5 finger breadths lateral to the midline of the spine on a level between the 5 th and the 6 th thoracic vertebrae.
- OTHER
-
Yoga
The participants in this arm will undergo a 60 min session of yoga exercises. These exercises are specifically designed for reflux symptoms by a yoga instructor. This includes a set of specific physical postures (asana) and breathing techniques within the four-element setup. The set of asana are divided into (a) standing, (b) sitting, and (c) lying down positions. The session will begin with asana in standing position, followed by a position called Shavasan (relaxation), then asana in sitting down position followed by Shavasan, finally asana in lying down position followed by Shavasan. At the end of all asana, Pranayam (special breathing exercises) will be practiced.
Sponsors & Collaborators
-
Kansas City Veteran Affairs Medical Center
collaborator FED -
Midwest Biomedical Research Foundation
lead OTHER
Principal Investigators
-
Prateek Sharma, MD · Kansas City VA Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2014-05-31
- Completion
- 2015-01-31
Countries
- United States
Study Locations
More Related Trials
-
The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux
NCT00462137 ·Status: COMPLETED
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome
NCT05312463 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
NCT05561179 ·Status: UNKNOWN ·Phase: NA
-
Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)
NCT05570448 ·Status: RECRUITING ·Phase: NA
-
Physiology of GERD and Treatment Response
NCT04292470 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Cardial Constriction Ligation (ECCL) for Refractory GERD Using a Disposable Endoscope
NCT07176221 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)
NCT06641375 ·Status: RECRUITING ·Phase: NA
-
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
NCT01574573 ·Status: TERMINATED ·Phase: NA
-
STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD
NCT02935881 ·Status: UNKNOWN ·Phase: PHASE3
-
The Efficacy of Neiguan (P6 Point) Acupressure in Patients With Gastroesophageal Reflux Disease (GERD)
NCT02255071 ·Status: UNKNOWN ·Phase: NA
-
Gastric Reflux and Sinonasal Symptoms
NCT04105894 ·Status: UNKNOWN
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
NCT05587322 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population
NCT00516971 ·Status: UNKNOWN ·Phase: NA
-
Gastroesophageal Reflux Disease Diagnostic Trial
NCT06504134 ·Status: NOT_YET_RECRUITING
-
Barrett's Esophagus & Gastroesophageal Reflux Disease
NCT00513331 ·Status: COMPLETED
-
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
NCT00587275 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy Of Hiatal Closure For GERD
NCT06280664 ·Status: RECRUITING
-
Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux Disease
NCT06106100 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
What is the Predictive Value of the Reflux Impact Scale
NCT00536328 ·Status: TERMINATED
-
Do Acid Sensing Ion Channels Contribute to Heartburn?
NCT01095133 ·Status: COMPLETED ·Phase: PHASE1
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
Acetic Acid for the Detection of Esophageal Neoplasms
NCT04054713 ·Status: SUSPENDED ·Phase: NA
-
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT01472939 ·Status: COMPLETED ·Phase: PHASE2